From: Neonatal effect of remifentanil in general anaesthesia for caesarean section: a randomized trial
Remifentanil group (n = 76) | Standard group (n = 75) | P | |
---|---|---|---|
Age (years) | 33.1 ± 5.1 | 32.3 ± 5.3 | 0.362 |
Weight prior to pregnancy (kg) | 68.1 ± 13.1 | 69.8 ± 13.4 | 0.473 |
Actual weight (kg) | 82.0 ± 13.4 | 81.4 ± 14.3 | 0.813 |
Height (cm) | 168.9 ± 6.8 | 167.6 ± 5.8 | 0.233 |
BMI (kg.m−2) | 24.0 ± 4.4 | 24.9 ± 5.0 | 0.254 |
Medical concomitant diseases | |||
Hypertension | 6 (8%) | 6 (8%) | 0.981 |
Asthma | 4 (5%) | 3 (4%) | 0.712 |
Thyreopathy | 3 (4%) | 3 (4%) | 0.987 |
Diabetes | 3 (4%) | 2 (3%) | 0.660 |
Placenta praevia centralis | 3 (4%) | 3 (4%) | 0.987 |
Other | 11 (14%) | 13 (17%) | 0.796 |
Newborns | |||
Weight of newborns (g) | 3162.9 ± 467 | 3122.5 ± 618 | 0.334 |
Gestational age (weeks) | 38.6 ± 1.1 | 38.9 ± 1.4 | 0.541 |